Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe change is limited to updating the page version label from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRecruitment status updated from Active, not recruiting to Recruiting. The page now includes a PubMed publications note and shows revision metadata (Revision: v3.3.1).SummaryDifference0.2%

- Check29 days agoChange DetectedA new site in Tainan, Taiwan (736) was added. The Tainan City, Taiwan (736) site was removed, altering the geographic footprint of participating centers.SummaryDifference0.2%

- Check43 days agoChange DetectedUpdated the India site entry to correct the spelling from Gūrgaon to Gurgaon, India (PIN 122001).SummaryDifference0.3%

- Check71 days agoChange DetectedUpdated operating-status messaging and versioning: adds a funding-status notice and current open status, replaces the old Last Update/Revision labels with new wording, and marks the revision as v3.2.0 while removing v3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedUpdates reflect a transition from v3.0.2 with August dates to v3.1.0 in September, with new status markers and contact info; overall meaning: the page is refreshed with current status and updated revision/version, while older August details are removed.SummaryDifference0.6%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.